- Mark Dransfield, University of Alabama at Birmingham
- Catherine Greene, Royal College of Surgeons in Ireland
- Joerg Mattes, University of Newcastle
- Montserrat Sanchez-Cespedes, Bellvitge Biomedical Research Institute-IDIBELL
- Giuseppe Verlato, University of Verona
- Catia Cornacchia, BioMed Central
Umeclidinium bromide (UMEC), an inhaled agent that facilitates relaxation of airway smooth muscle, improves lung function over 24 hours in patients with moderate-to-severe COPD and is generally well-tolerated indicating it may prove a successful treatment for this condition.
BMC Pulmonary Medicine 2014, 14:27
News from the web
BMC Pulmonary Medicine is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.
Join the Editorial Board!
Are you interested in becoming an Editorial Board member for BMC Pulmonary Medicine and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at email@example.com, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.
BMC series blog
- 04 March 2014
- Highlights of the BMC-series: February 2014
- 03 March 2014
- Hiding the truth – how one bird fools another
- 27 February 2014
- BMC Medical Imaging at the European Congress of Radiology 2014